
Telum Therapeutics has raised €18m in Series A financing to advance its lead antimicrobial programme into phase 1 clinical development …
Jennings becomes President of Beckman Coulter Diagnostics
Boyds expands Regulatory Affairs team to support growing demand
Sterling doubles ADC manufacturing capacity at Welsh facility
Femtosecond laser cuts lung tumour margin assessment time

